Form 8-K - Current report:
SEC Accession No. 0001493152-24-041802
Filing Date
2024-10-21
Accepted
2024-10-21 17:10:26
Documents
15
Period of Report
2024-10-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42607
2 ex99-1.htm EX-99.1 17848
3 ex99-1_001.jpg GRAPHIC 1625
  Complete submission text file 0001493152-24-041802.txt   248349

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mgrx-20241021.xsd EX-101.SCH 3033
5 XBRL LABEL FILE mgrx-20241021_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE mgrx-20241021_pre.xml EX-101.PRE 24177
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3848
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 241384105
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)